Water

Generic Name: Water

Brand Names: Activase, Alphanate, Alphanine Sd, Eye Stream, Hiberix, Koate, Nuwiq, Profilnine, Prolastin, Serostim, Thrombate III

Drug Type: Small Molecule

Chemical Formula: H_₂O

CAS Number: 7732-18-5

Unique Ingredient Identifier: 059QF0KO0R

Background: Water (chemical formula: H2O) is a transparent fluid which forms the world's streams, lakes, oceans and rain, and is the major constituent of the fluids of organisms. As a chemical compound, a water molecule contains one oxygen and two hydrogen atoms that are connected by covalent bonds. Water is a liquid at standard ambient temperature and pressure, but it ...

Indication: For diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered [FDA Label].

Associated Conditions: -

Associated Therapies: Irrigation of the ocular surface therapy, Parenteral drug administration

Clinical Trials

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Vehicle pre foam formulation
Drug: azelaic acid pre foam formulation
Drug: Water

First Posted Date: 2011-09-08

Last Posted Date: 2020-04-01

Lead Sponsor: LEO Pharma

Target Recruit Count: 240

Registration Number: NCT01430533

Locations: 🇺🇸
Robert I. Cooper, MD, Fargo, North Dakota, United States

L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia

Phase 3

Completed

Conditions: Hypothyroxinemia

Interventions: Drug: water
Drug: L-Thyroxine

First Posted Date: 2011-03-01

Last Posted Date: 2018-08-10

Lead Sponsor: Centre Hospitalier Universitaire, Amiens

Target Recruit Count: 50

Registration Number: NCT01306227

Locations: 🇫🇷
Caen University Hospital, Caen, Basse Normandie, France
🇫🇷
Lens Hospital, Lens, Nord- Pas De Calais, France
🇫🇷
Amiens University Hospital, Amiens, Picardie, France

Dexamethasone Efficacy in HELLP I Syndrome

Phase 3

Conditions: HELLP Syndrome

Interventions: Drug: sterile water
Drug: Dexamethasone

First Posted Date: 2010-06-07

Last Posted Date: 2010-06-07

Lead Sponsor: Universidad del Valle, Colombia

Target Recruit Count: 160

Registration Number: NCT01138839

Locations: 🇨🇴
Universidad del Valle, Cali, Valle, Colombia

Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion

Phase 2

Completed

Conditions: Tooth Erosion

Interventions: Drug: Sodium fluoride
Drug: Sterile water
Drug: Sodium monoflurophosphate

First Posted Date: 2010-05-24

Last Posted Date: 2015-01-01

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 36

Registration Number: NCT01128972

Locations: 🇺🇸
Indiana University School of Dentistry, Indianapolis, Indiana, United States

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

Not Applicable

Completed

Conditions: Chronic Daily Headache

Interventions: Drug: Syntocinon
Drug: Sterile water

First Posted Date: 2009-08-20

Last Posted Date: 2023-06-15

Lead Sponsor: MedVadis Research Corporation

Target Recruit Count: 60

Registration Number: NCT00963040

Locations: 🇺🇸
MedVadis Research Corporation, Wellesley Hills, Massachusetts, United States

Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy

Phase 3

Completed

Conditions: Gynecological Laparoscopy

Interventions: Drug: 10 mLRopivacaine 1%
Drug: Water for injection
Drug: 10 mL Ropivacaine 1%

First Posted Date: 2009-06-25

Last Posted Date: 2011-06-28

Lead Sponsor: Carmel Medical Center

Target Recruit Count: 40

Registration Number: NCT00927979

Skin Blood Flow Changes Using Laser Doppler Imager for Assessment of Pain and Analgesia in Newborn Infants

Phase 4

Completed

Conditions: Procedural Pain

Interventions: Drug: sucrose 24% oral solution
Drug: sterile water

First Posted Date: 2008-06-10

Last Posted Date: 2008-06-10

Lead Sponsor: Children's Hospital of Michigan

Target Recruit Count: 56

Registration Number: NCT00694174

Locations: 🇺🇸
Hutzel Women's University Hospital, The Detroit Medical Center, Detroit, Michigan, United States

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Phase 2

Completed

Conditions: HIV I Infection

Interventions: Drug: Vacc-4x
Drug: Sterile water

First Posted Date: 2008-04-16

Last Posted Date: 2017-02-23

Lead Sponsor: Bionor Immuno AS

Target Recruit Count: 137

Registration Number: NCT00659789

Locations: 🇩🇪
Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
🇪🇸
Hospital Clinic i Provincial, Barcelona, Spain
🇪🇸
Hospital Germans Trias i Pujol, Badalona, Spain

and more 15 locations

Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children

Phase 3

Completed

Conditions: Pain

Interventions: Drug: Sterile water
Drug: Fentanyl

First Posted Date: 2006-11-30

Last Posted Date: 2010-12-13

Lead Sponsor: The Hospital for Sick Children

Target Recruit Count: 64

Registration Number: NCT00405444

Locations: 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada

Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction

Phase 4

Completed

Conditions: Small Bowel Obstruction

Interventions: Drug: gastrograffin
Drug: water

First Posted Date: 2006-10-18

Last Posted Date: 2011-02-25

Lead Sponsor: University Hospital, Rouen

Target Recruit Count: 242

Registration Number: NCT00389116

Locations: 🇫🇷
CHU, Rouen, France

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy